nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—EV release from cardiac cells and their functional effects—ERBB4—gallbladder cancer	0.0544	0.055	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Alpha-synuclein signaling—UCHL1—gallbladder cancer	0.0394	0.0399	CbGpPWpGaD
Pseudoephedrine—NFATC1—Heart Development—ERBB3—gallbladder cancer	0.0343	0.0347	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Parkinsons Disease Pathway—UCHL1—gallbladder cancer	0.0335	0.0339	CbGpPWpGaD
Pseudoephedrine—IL2—IL2 signaling events mediated by STAT5—BCL2—gallbladder cancer	0.0255	0.0258	CbGpPWpGaD
Pseudoephedrine—IL2—IL2 signaling events mediated by PI3K—BCL2—gallbladder cancer	0.0215	0.0218	CbGpPWpGaD
Pseudoephedrine—IL2—IL-5 Signaling Pathway—BCL2—gallbladder cancer	0.0202	0.0205	CbGpPWpGaD
Pseudoephedrine—IL2—IL-2 Signaling Pathway—BCL2—gallbladder cancer	0.0194	0.0197	CbGpPWpGaD
Pseudoephedrine—NFATC1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BCL2—gallbladder cancer	0.0188	0.019	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—BCL2—gallbladder cancer	0.0159	0.0161	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin receptor SHC signaling—HRAS—gallbladder cancer	0.0145	0.0147	CbGpPWpGaD
Pseudoephedrine—TNF—Overview of nanoparticle effects—BCL2—gallbladder cancer	0.0136	0.0138	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-2 signaling—NRAS—gallbladder cancer	0.0131	0.0133	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—ERBB4—gallbladder cancer	0.013	0.0132	CbGpPWpGaD
Pseudoephedrine—IL2—IL-5 Signaling Pathway—KRAS—gallbladder cancer	0.0129	0.013	CbGpPWpGaD
Pseudoephedrine—IL2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.0122	0.0123	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.0118	0.012	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—NRAS—gallbladder cancer	0.0118	0.0119	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—KEAP1—gallbladder cancer	0.0117	0.0118	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-2 signaling—KRAS—gallbladder cancer	0.0113	0.0114	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—ERBB3—gallbladder cancer	0.0113	0.0114	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—NRAS—gallbladder cancer	0.0111	0.0112	CbGpPWpGaD
Pseudoephedrine—TNF—RXR and RAR heterodimerization with other nuclear receptor—BCL2—gallbladder cancer	0.0106	0.0107	CbGpPWpGaD
Pseudoephedrine—IL2—IL-2 Signaling Pathway—HRAS—gallbladder cancer	0.0105	0.0106	CbGpPWpGaD
Pseudoephedrine—IL2—Corticotropin-releasing hormone—BCL2—gallbladder cancer	0.0104	0.0105	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.0102	0.0103	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-3, 5 and GM-CSF signaling—HRAS—gallbladder cancer	0.0101	0.0103	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—KRAS—gallbladder cancer	0.0101	0.0102	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—EGFR—gallbladder cancer	0.0101	0.0102	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—KEAP1—gallbladder cancer	0.01	0.0101	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.01	0.0101	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-2 signaling—HRAS—gallbladder cancer	0.00961	0.00972	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—KRAS—gallbladder cancer	0.00956	0.00967	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—gallbladder cancer	0.00931	0.00942	CbGpPWpGaD
Pseudoephedrine—IL2—Regulation of Telomerase—EGFR—gallbladder cancer	0.00891	0.00901	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—KEAP1—gallbladder cancer	0.00889	0.00899	CbGpPWpGaD
Pseudoephedrine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—BCL2—gallbladder cancer	0.00878	0.00888	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00866	0.00876	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—TP53—gallbladder cancer	0.00864	0.00874	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.00862	0.00872	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—HRAS—gallbladder cancer	0.0086	0.0087	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—HRAS—gallbladder cancer	0.00856	0.00866	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—HRAS—gallbladder cancer	0.00812	0.00822	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—BCL2—gallbladder cancer	0.00784	0.00793	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—TP53—gallbladder cancer	0.00766	0.00775	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.00761	0.0077	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00733	0.00741	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—TP53—gallbladder cancer	0.00731	0.00739	CbGpPWpGaD
Pseudoephedrine—TNF—FAS pathway and Stress induction of HSP regulation—BCL2—gallbladder cancer	0.00724	0.00732	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.00707	0.00715	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—HRAS—gallbladder cancer	0.00676	0.00684	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—NRAS—gallbladder cancer	0.00675	0.00683	CbGpPWpGaD
Pseudoephedrine—TNF—Ceramide signaling pathway—BCL2—gallbladder cancer	0.0065	0.00658	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.00644	0.00651	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KEAP1—gallbladder cancer	0.00621	0.00628	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—KRAS—gallbladder cancer	0.00581	0.00588	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—EGFR—gallbladder cancer	0.00573	0.0058	CbGpPWpGaD
Pseudoephedrine—TNF—Caspase Cascade in Apoptosis—BCL2—gallbladder cancer	0.00567	0.00573	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.00561	0.00567	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.00538	0.00544	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KEAP1—gallbladder cancer	0.00525	0.00531	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.00511	0.00517	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—ERBB4—gallbladder cancer	0.00507	0.00513	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00497	0.00503	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—HRAS—gallbladder cancer	0.00494	0.005	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.0049	0.00496	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.00483	0.00488	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—gallbladder cancer	0.00481	0.00487	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 signaling events—EGFR—gallbladder cancer	0.00465	0.00471	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.00463	0.00468	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00453	0.00458	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00453	0.00458	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—gallbladder cancer	0.00443	0.00448	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—ERBB3—gallbladder cancer	0.00438	0.00443	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00429	0.00434	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00428	0.00433	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—BCL2—gallbladder cancer	0.00416	0.0042	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.00393	0.00398	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.00373	0.00377	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00364	0.00368	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.00321	0.00324	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—HRAS—gallbladder cancer	0.0032	0.00324	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00315	0.00319	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB4—gallbladder cancer	0.00295	0.00299	CbGpPWpGaD
Pseudoephedrine—IL2—epithelium—gallbladder cancer	0.00291	0.252	CbGeAlD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—NRAS—gallbladder cancer	0.00286	0.00289	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—gallbladder cancer	0.00285	0.00288	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—BCL2—gallbladder cancer	0.00283	0.00286	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—ERBB2—gallbladder cancer	0.00275	0.00278	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00273	0.00276	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB4—gallbladder cancer	0.00272	0.00276	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00271	0.00274	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB3—gallbladder cancer	0.00255	0.00258	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—BCL2—gallbladder cancer	0.00255	0.00258	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB4—gallbladder cancer	0.0025	0.00252	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—gallbladder cancer	0.00247	0.0025	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.00246	0.00249	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB3—gallbladder cancer	0.00236	0.00238	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—gallbladder cancer	0.00235	0.00238	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.00231	0.00233	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB3—gallbladder cancer	0.00216	0.00218	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00215	0.00218	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—EGFR—gallbladder cancer	0.00213	0.00216	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00209	0.00212	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00209	0.00211	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—NRAS—gallbladder cancer	0.00209	0.00211	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—NRAS—gallbladder cancer	0.00196	0.00199	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB4—gallbladder cancer	0.00191	0.00193	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EGFR—gallbladder cancer	0.0019	0.00193	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—gallbladder cancer	0.00188	0.0019	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—KRAS—gallbladder cancer	0.0018	0.00182	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—gallbladder cancer	0.00179	0.00181	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.00176	0.00178	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—KRAS—gallbladder cancer	0.00169	0.00171	CbGpPWpGaD
Pseudoephedrine—IL2—liver—gallbladder cancer	0.00165	0.143	CbGeAlD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB3—gallbladder cancer	0.00165	0.00167	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—BCL2—gallbladder cancer	0.00165	0.00167	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB4—gallbladder cancer	0.00161	0.00163	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.00161	0.00163	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB2—gallbladder cancer	0.0016	0.00162	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HRAS—gallbladder cancer	0.00153	0.00155	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.00152	0.00154	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—gallbladder cancer	0.0015	0.00152	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB2—gallbladder cancer	0.00148	0.00149	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00145	0.00147	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—gallbladder cancer	0.00144	0.00146	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—gallbladder cancer	0.00144	0.00145	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB3—gallbladder cancer	0.00139	0.00141	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—BCL2—gallbladder cancer	0.00139	0.00141	CbGpPWpGaD
Pseudoephedrine—NFATC1—lymph node—gallbladder cancer	0.00138	0.12	CbGeAlD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00137	0.00139	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—gallbladder cancer	0.00135	0.00137	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB2—gallbladder cancer	0.00135	0.00137	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00135	0.00137	CbGpPWpGaD
Pseudoephedrine—TNF—lymph node—gallbladder cancer	0.00132	0.114	CbGeAlD
Pseudoephedrine—IL2—lymph node—gallbladder cancer	0.00126	0.109	CbGeAlD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00122	0.00123	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NRAS—gallbladder cancer	0.00122	0.00123	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NRAS—gallbladder cancer	0.00113	0.00114	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NRAS—gallbladder cancer	0.00112	0.00114	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—gallbladder cancer	0.00111	0.00112	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00107	0.00108	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KRAS—gallbladder cancer	0.00105	0.00106	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB2—gallbladder cancer	0.00103	0.00105	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NRAS—gallbladder cancer	0.00103	0.00104	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—gallbladder cancer	0.00103	0.00104	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—gallbladder cancer	0.00102	0.00104	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00099	0.001	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000988	0.001	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ERBB2—gallbladder cancer	0.000979	0.00099	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—KRAS—gallbladder cancer	0.00097	0.000981	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KRAS—gallbladder cancer	0.000967	0.000978	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—gallbladder cancer	0.000938	0.000949	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.0009	0.000911	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—gallbladder cancer	0.00089	0.000901	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KRAS—gallbladder cancer	0.000886	0.000896	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB2—gallbladder cancer	0.000875	0.000885	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000851	0.000861	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—gallbladder cancer	0.000824	0.000834	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—gallbladder cancer	0.000822	0.000832	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—gallbladder cancer	0.000816	0.000826	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NRAS—gallbladder cancer	0.000787	0.000796	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—gallbladder cancer	0.000759	0.000768	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—gallbladder cancer	0.000753	0.000762	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NRAS—gallbladder cancer	0.000744	0.000753	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000723	0.000731	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—gallbladder cancer	0.000717	0.000725	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—gallbladder cancer	0.000678	0.000686	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KRAS—gallbladder cancer	0.000677	0.000685	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRAS—gallbladder cancer	0.000665	0.000673	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KRAS—gallbladder cancer	0.000641	0.000648	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—gallbladder cancer	0.000606	0.000613	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—gallbladder cancer	0.000602	0.000609	CbGpPWpGaD
Pseudoephedrine—ADRA1A—epithelium—gallbladder cancer	0.000577	0.0499	CbGeAlD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—gallbladder cancer	0.000576	0.000582	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KRAS—gallbladder cancer	0.000573	0.000579	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—gallbladder cancer	0.000545	0.000551	CbGpPWpGaD
Pseudoephedrine—MAOA—pancreas—gallbladder cancer	0.000509	0.0441	CbGeAlD
Pseudoephedrine—IL2—Signaling Pathways—TP53—gallbladder cancer	0.000509	0.000515	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB4—gallbladder cancer	0.000506	0.000512	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB4—gallbladder cancer	0.000495	0.000501	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—gallbladder cancer	0.000487	0.000493	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NRAS—gallbladder cancer	0.000463	0.000468	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB3—gallbladder cancer	0.000438	0.000443	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB3—gallbladder cancer	0.000428	0.000433	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB4—gallbladder cancer	0.00041	0.000414	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KRAS—gallbladder cancer	0.000399	0.000403	CbGpPWpGaD
Pseudoephedrine—ADRA2A—pancreas—gallbladder cancer	0.000391	0.0338	CbGeAlD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB4—gallbladder cancer	0.000381	0.000385	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—gallbladder cancer	0.000354	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB3—gallbladder cancer	0.000354	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NRAS—gallbladder cancer	0.000353	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NRAS—gallbladder cancer	0.000346	0.00035	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—gallbladder cancer	0.000339	0.000343	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB3—gallbladder cancer	0.000329	0.000333	CbGpPWpGaD
Pseudoephedrine—ADRA1A—liver—gallbladder cancer	0.000327	0.0283	CbGeAlD
Pseudoephedrine—MAOA—liver—gallbladder cancer	0.000324	0.028	CbGeAlD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—gallbladder cancer	0.000322	0.000326	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—gallbladder cancer	0.000315	0.000319	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—gallbladder cancer	0.000304	0.000308	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—gallbladder cancer	0.000298	0.000301	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NRAS—gallbladder cancer	0.000286	0.000289	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—gallbladder cancer	0.000274	0.000278	CbGpPWpGaD
Pseudoephedrine—SLC6A2—lymph node—gallbladder cancer	0.00027	0.0233	CbGeAlD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—gallbladder cancer	0.000268	0.000272	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NRAS—gallbladder cancer	0.000266	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—gallbladder cancer	0.000261	0.000264	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—gallbladder cancer	0.000259	0.000262	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—gallbladder cancer	0.000253	0.000256	CbGpPWpGaD
Pseudoephedrine—MAOA—lymph node—gallbladder cancer	0.000248	0.0215	CbGeAlD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—gallbladder cancer	0.000246	0.000249	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—gallbladder cancer	0.000242	0.000245	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—gallbladder cancer	0.000229	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—gallbladder cancer	0.000222	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—gallbladder cancer	0.000209	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRAS—gallbladder cancer	0.000209	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—gallbladder cancer	0.000206	0.000209	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRAS—gallbladder cancer	0.000204	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—gallbladder cancer	0.000194	0.000197	CbGpPWpGaD
Pseudoephedrine—CYP2D6—liver—gallbladder cancer	0.000193	0.0167	CbGeAlD
Pseudoephedrine—ADRA2A—lymph node—gallbladder cancer	0.000191	0.0165	CbGeAlD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—gallbladder cancer	0.00019	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—gallbladder cancer	0.000186	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—gallbladder cancer	0.00018	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—gallbladder cancer	0.000176	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRAS—gallbladder cancer	0.000169	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—gallbladder cancer	0.00016	0.000162	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRAS—gallbladder cancer	0.000157	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—gallbladder cancer	0.000156	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—gallbladder cancer	0.000154	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—gallbladder cancer	0.000153	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—gallbladder cancer	0.000149	0.000151	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—gallbladder cancer	0.000145	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—gallbladder cancer	0.000143	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—gallbladder cancer	0.000135	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—gallbladder cancer	0.000129	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—gallbladder cancer	0.000124	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—gallbladder cancer	0.00012	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—gallbladder cancer	0.000115	0.000116	CbGpPWpGaD
